International Clinical Trial: Research on CCNI-Targeted High-Throughput Virtual Inhibitor Screening and Its Association with Clinical Prognosis in Patients with Traumatic Brain Injury

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122527) titled 'Research on CCNI-Targeted High-Throughput Virtual Inhibitor Screening and Its Association with Clinical Prognosis in Patients with Traumatic Brain Injury' on April 14.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Zigong Fourth People's Hospital(Zigong First-aid Center)

Condition: Traumatic brain injury (including mild, moderate, and severe TBI)

Intervention: Severe TBI group:None Mild TBI group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-17

Target Sample Size: Severe TBI group:30;Mild TBI group:30;Severe TBI group:30;

Countries...